This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Indonesia, based on in-depth interviews conducted with leaders and pioneers across the value chain, from the Ministries of Health and Industry, the leaders of the Indonesian public procurement and social security institutes, country managers of the world’s leading biopharmaceutical companies, and representatives from local SMEs and service providers.
Disappointing but Not Surprising: Moderna’s Withdrawal from Manufacturing…
Medicines for Africa’s Lenias Hwenda reflects on Moderna’s recent decision not to go ahead with plans for a vaccine manufacturing facility in Kenya, and why local production remains crucial to…